Medifast Inc financial data

Symbol
MED on NYSE
Location
11445 Cronhill Drive, Owings Mills, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 387 % +37.4%
Quick Ratio 62.1 % +9.06%
Debt-to-equity 29.4 % -35%
Return On Equity 0.12 % -96.8%
Return On Assets 0.09 % -96.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11M shares +0.49%
Common Stock, Shares, Outstanding 11M shares +0.49%
Entity Public Float 230M USD -77%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 11M shares +0.49%
Weighted Average Number of Shares Outstanding, Diluted 11M shares +0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 430M USD -36.3%
Cost of Revenue 118M USD -33%
Operating Income (Loss) -5.7M USD -153%
Nonoperating Income (Expense) 7.72M USD +425%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.02M USD -83.6%
Income Tax Expense (Benefit) 1.77M USD -64.5%
Net Income (Loss) Attributable to Parent 247K USD -96.6%
Earnings Per Share, Basic 0 USD/shares -95.5%
Earnings Per Share, Diluted 0 USD/shares -96.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99.5M USD -13.7%
Cash, Cash Equivalents, and Short-term Investments 173M USD +0.09%
Inventory, Net 23.2M USD -42.1%
Assets, Current 208M USD -7.62%
Deferred Income Tax Assets, Net 12.1M USD +203%
Property, Plant and Equipment, Net 32.8M USD -15.8%
Operating Lease, Right-of-Use Asset 8.4M USD -31.7%
Other Assets, Noncurrent 7.02M USD -36%
Assets 268M USD -7.91%
Contract with Customer, Liability, Current 316K USD -44.9%
Liabilities, Current 46.7M USD -35.5%
Operating Lease, Liability, Noncurrent 6.79M USD -41.1%
Liabilities 53.5M USD -36.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 220K USD -37%
Retained Earnings (Accumulated Deficit) 176M USD +0.15%
Stockholders' Equity Attributable to Parent 215M USD +3.55%
Liabilities and Equity 268M USD -7.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.41M USD -53.2%
Net Cash Provided by (Used in) Financing Activities -563K USD +62.2%
Net Cash Provided by (Used in) Investing Activities -2.05M USD +26%
Common Stock, Shares Authorized 20M shares 0%
Common Stock, Shares, Issued 11M shares +0.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 789K USD -74%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 99.5M USD -13.7%
Deferred Tax Assets, Valuation Allowance 1.62M USD -3.33%
Deferred Tax Assets, Gross 20.5M USD +0.09%
Operating Lease, Liability 12.3M USD -30.4%
Payments to Acquire Property, Plant, and Equipment 1.52M USD -17.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 118K USD -98.4%
Lessee, Operating Lease, Liability, to be Paid 12.7M USD -30.6%
Property, Plant and Equipment, Gross 95.9M USD -2.94%
Operating Lease, Liability, Current 5.47M USD -10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.79M USD -41.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.78M USD -26%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) 20K USD -82.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 410K USD -34.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.9M USD +13.4%
Deferred Tax Assets, Operating Loss Carryforwards 2.73M USD -5.24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.5M shares 0%
Unrecognized Tax Benefits 7.43M USD -0.92%
Lessee, Operating Lease, Liability, to be Paid, Year Four 525K USD -79.9%
Operating Lease, Payments 1.6M USD +2.37%
Additional Paid in Capital 38.2M USD +23.3%
Depreciation, Depletion and Amortization 3.28M USD +0.58%
Share-based Payment Arrangement, Expense 7.6M USD -0.33%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%